- Home
- NMRA vs CARS Comparison
NMRA vs CARS Comparison
Compare NMRA & CARS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NMRA | CARS |
|---|---|---|
| Founded | 2019 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Motor Vehicles |
| Sector | | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 554.0M | 476.1M |
| IPO Year | 2023 | 2017 |
Fundamental Metrics
Financial Performance| Metric | NMRA | CARS |
|---|---|---|
| Price | $1.84 | $9.63 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 6 |
| Target Price | $7.50 | ★ $16.00 |
| AVG Volume (30 Days) | ★ 1.4M | 763.1K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 5.23 | N/A |
| EPS | N/A | ★ 0.08 |
| Revenue | N/A | ★ $723,239,000.00 |
| Revenue This Year | N/A | $3.03 |
| Revenue Next Year | N/A | $2.57 |
| P/E Ratio | ★ N/A | $119.38 |
| Revenue Growth | N/A | ★ 0.57 |
| 52 Week Low | $0.66 | $7.40 |
| 52 Week High | $3.65 | $13.97 |
Technical Indicators
Market Signals| Indicator | NMRA | CARS |
|---|---|---|
| Relative Strength Index (RSI) | 43.45 | 39.78 |
| Support Level | $1.81 | $7.64 |
| Resistance Level | $1.90 | $12.54 |
| Average True Range (ATR) | 0.18 | 0.47 |
| MACD | -0.01 | -0.23 |
| Stochastic Oscillator | 26.32 | 7.34 |
Price Performance
Historical ComparisonAbout NMRA Neumora Therapeutics Inc.
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.
About CARS Cars.com Inc.
Cars.com Inc is an audience-powered and data-driven technology platform that simplifies buying and selling cars. The flagship Cars.com marketplace connects consumers to dealerships across the U.S., powering the car-buying experience with artificial intelligence (AI) shopping tools, vehicle reviews and content. Its ecosystem of products enables dealers and OEMs to sell more cars by leveraging the marketplace, dealer websites, trade and appraisal tools and proprietary in-market media solutions. The platform provides shoppers with data, resources and digital tools to make informed buying decisions and connect with automotive retailers. The Company also provides dealerships and OEMs with solutions and data-driven intelligence to reach and influence its 26 million monthly shoppers.